Clinical Trial Update: Ribavirin for Patients With Recurrent/Metastatic (R/M) Human Papillomavirus (HPV)-Related Malignancies [NA]

View source ↗

Summary

Clinical trial update for ribavirin in patients with recurrent/metastatic HPV-related malignancies; study completed with results posted in 2023.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hpv-related Malignancies
• Human Papillomavirus -related Malignancies

Drugs mentioned

• Ribavirin (ribavirin)

Snippet

Sponsor: Memorial Sloan Kettering Cancer Center | Conditions: Human Papillomavirus (HPV)-Related Malignancies, Recurrent/Metastatic (R/M) Human Papillomavirus (HPV)-Related Malignancies | NA | Status: COMPLETED | Results posted: 2023-01-05